FDA.reportPublic FDA data

Xofluza

Product NDC
50242-860
11-digit product format
502420860
Labeler code
50242
Product ID
50242-860_c2da90f4-a11c-46d2-be18-53d286b084cf
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BALOXAVIR MARBOXIL
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Genentech, Inc.
Application
NDA210854
Marketing category
NDA
Marketing start
2018-10-24
Substance
BALOXAVIR MARBOXIL
Active strength
40 mg/1
Pharmacologic classes
Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Xofluza
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BALOXAVIR MARBOXIL40 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii505CXM6OHG
Rxcui2100008, 2100010, 2467537, 2467539, 2536740, 2536742, 2716798, 2716800

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e77882ec-c16a-4b71-b3f9-3d7ef83d1aedProduct name220260310

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50242-860-01Xofluza1 in 1 BLISTER PACKTABLET, FILM COATED130
50242-860-01Xofluza1 in 1 CARTONTABLET, FILM COATED130
50242-860-86Xofluza1 in 1 BLISTER PACKTABLET, FILM COATED130
50242-860-86Xofluza1 in 1 CARTONTABLET, FILM COATED130

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50242-860-01EA - Each50242-8602534f46c-8519-4db9-969c-0279e644613d12021-08-05
50242-860-02EA - Each50242-8606bb83968-8fbb-45ef-bd3b-5da61db53e6b12018-11-06
50242-860-87EA - Each50242-8603b918c73-6702-49e7-b78e-224d4853a87a12019-03-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50242-860XOFLUZA (BALOXAVIR MARBOXIL) TABLET, FILM COATED XOFLUZA (BALOXAVIR MARBOXIL) GRANULE, FOR SOLUTION [GENENTECH, INC.]27Current NDC, Legacy NDC, 4 package rows20250326_e49e1a61-1b7c-4be5-ac84-af6240b511e7.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2716798baloxavir marboxil 30 MG Granules for Oral SuspensionPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2467537baloxavir marboxil 40 MG Granules for Oral SuspensionPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100008baloxavir marboxil 40 MG Oral TabletPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2536740baloxavir marboxil 80 MG Oral TabletPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2716800Xofluza 30 MG Granules for Oral SuspensionPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2467539Xofluza 40 MG Granules for Oral SuspensionPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100010Xofluza 40 MG Oral TabletPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2536742Xofluza 80 MG Oral TabletPSNe49e1a61-1b7c-4be5-ac84-af6240b511e730
2716800baloxavir marboxil 30 MG Granules for Oral Suspension [Xofluza]SBDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2467539baloxavir marboxil 40 MG Granules for Oral Suspension [Xofluza]SBDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100010baloxavir marboxil 40 MG Oral Tablet [Xofluza]SBDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2536742baloxavir marboxil 80 MG Oral Tablet [Xofluza]SBDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2716798baloxavir marboxil 30 MG Granules for Oral SuspensionSCDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2467537baloxavir marboxil 40 MG Granules for Oral SuspensionSCDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100008baloxavir marboxil 40 MG Oral TabletSCDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2536740baloxavir marboxil 80 MG Oral TabletSCDe49e1a61-1b7c-4be5-ac84-af6240b511e730
2716800Xofluza 30 MG Granules for Oral SuspensionSYe49e1a61-1b7c-4be5-ac84-af6240b511e730
2467539Xofluza 40 MG Granules for Oral SuspensionSYe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100010Xofluza 40 MG Oral TabletSYe49e1a61-1b7c-4be5-ac84-af6240b511e730
2536742Xofluza 80 MG Oral TabletSYe49e1a61-1b7c-4be5-ac84-af6240b511e730
2100100{2 (baloxavir marboxil 40 MG Oral Tablet [Xofluza]) } Pack [Xofluza 80 MG Dose Pack (2 x 40 MG Tablets)]BPCK325b077a-8fe2-435c-be70-df9579862e135
2100026{2 (baloxavir marboxil 40 MG Oral Tablet) } PackGPCK325b077a-8fe2-435c-be70-df9579862e135
2100008baloxavir marboxil 40 MG Oral TabletPSN325b077a-8fe2-435c-be70-df9579862e135
2100026baloxavir marboxil 80 MG Dose Pack (2 x 40 MG Tablets)PSN325b077a-8fe2-435c-be70-df9579862e135
2100010Xofluza 40 MG Oral TabletPSN325b077a-8fe2-435c-be70-df9579862e135
2100100Xofluza 80 MG Dose Pack (2 x 40 MG Tablets)PSN325b077a-8fe2-435c-be70-df9579862e135
2100010baloxavir marboxil 40 MG Oral Tablet [Xofluza]SBD325b077a-8fe2-435c-be70-df9579862e135
2100008baloxavir marboxil 40 MG Oral TabletSCD325b077a-8fe2-435c-be70-df9579862e135
2100026baloxavir marboxil 80 MG Dose Pack (2 x 40 MG Tablets)SY325b077a-8fe2-435c-be70-df9579862e135
2100010Xofluza 40 MG Oral TabletSY325b077a-8fe2-435c-be70-df9579862e135
2100100Xofluza 80 MG Dose Pack (2 x 40 MG Tablets)SY325b077a-8fe2-435c-be70-df9579862e135

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50242-860-01502420860011 BLISTER PACK in 1 CARTON (50242-860-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2021-03-260000-00-00NoNoCurrent
50242-860-02502420860021 BLISTER PACK in 1 CARTON (50242-860-02) > 2 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2018-10-242022-06-30NoNoCurrent
50242-860-86502420860861 BLISTER PACK in 1 CARTON (50242-860-86) / 1 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2021-08-310000-00-00YesNoCurrent
50242-860-87502420860871 BLISTER PACK in 1 CARTON (50242-860-87) > 2 TABLET, FILM COATED in 1 BLISTER PACK1 blister pack2018-10-242022-06-30YesNoCurrent